CELL ENCAPSULATION
Body Armour for Living Cells: protects, shields and extends the life of living cells

Micro-encapsulation of living cells for immuno-protection and localization in patients

Encapsulation of probiotic bacteria and yeast for stomach acid protection and ambient storage
Our Services
To find out more about our unique award winning protective cell encapsulation technology and our cell biology expertise, click a panel on the right.
Encapsulated
Cell-in-a-box
Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, store and transport human and animal cells.
The Cell-in-a-Box® technology builds a porous capsule round the cells, allowing free diffusion of nutrients in, and waste products out, and also allowing any biological molecules synthesized by the cells to escape.
BAC-in-a-box
Bac-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, store and transport living bacteria and yeast.
Bac-in-a-Box® technology builds a porous capsule round the bacteria or yeast, allowing free diffusion of nutrients in, and waste products out, and also allowing the bacteria and yeast to grow in the capsules.
They can then be released from the capsule.
Non Encapsulated
STEM CELL MANUFACTURING
CELL LINE DEVELOPMENT
GMP CELL BANKING (GMP4Cells)
Austrianova is a B2B company that offers a full GMP service for living eukaryotic human and animal cells. We can prepare cell banks and process cell lines in a US-FDA compliant manner. We can grow up adherent or non-adherent qualified cells (supplied with the necessary documentation as to sterility and adventitious micro-organisms)
News and Recent Publications
Austrianova/SGAustria: 2022 – a year in review
Austrianova/SGAustria is pleased to announce that during the last year it has made major progress and achieved some significant milestones. During 2022, as well as our ongoing projects, the Company has acquired three new partners all involved in cutting edge therapy...
Austrianova updates on the GMP aspects of its Cell-in-a-Box® clinical products
' ''' ' All therapeutics go through three phasese of clinical trial testing (phase 1, 2 and 3) before market authorization is possible and they are approved for use in patients. Because late stage clinical trials involve more subjects than early stage trials, larger...